| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.4 |